Vanguards of Health Care by Bloomberg Intelligence
CVRx Aims to Treat the Heart Remotely
13 Sep 2023
CVRx’s baroreflex activation therapy (BAT) technology can potentially treat heart failure for millions of patients without taking up precious real estate within the heart, CEO Nadim Yared explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Nadim sits down with BI analyst Matt Henriksson for an in-depth interview about the company, including recent developments in BAT and how its Barostim NEO, an implantable pulse generator, works for heart-failure patients even though it’s placed away from the organ.See omnystudio.com/listener for privacy information.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other episodes from Vanguards of Health Care by Bloomberg Intelligence
Transcribed and ready to explore now
Aegis Ventures’ Blueprint for Building AI-Native Companies
04 Dec 2025
Vanguards of Health Care by Bloomberg Intelligence
Beta Bionics Does the Work to Reduce Insulin Pump Burden
20 Nov 2025
Vanguards of Health Care by Bloomberg Intelligence
Fosun Pharma’s Drive Beyond China
17 Nov 2025
Vanguards of Health Care by Bloomberg Intelligence
ARS Pharma’s Clinical Differentiation
13 Nov 2025
Vanguards of Health Care by Bloomberg Intelligence
Biolinq Introduces New Silicon Tech Opens Next Chapter of Glucose and Analyte Detection
06 Nov 2025
Vanguards of Health Care by Bloomberg Intelligence
Recapping ESMO, Inside AstraZeneca’s Bold Bet on Antibody Drug Conjugates
27 Oct 2025
Vanguards of Health Care by Bloomberg Intelligence